Assuntos
Infecções por Klebsiella/imunologia , Klebsiella pneumoniae/imunologia , Lipocalina-2/deficiência , Macrófagos/imunologia , Pneumonia Bacteriana/imunologia , Mucosa Respiratória/imunologia , Animais , Infecções por Klebsiella/genética , Infecções por Klebsiella/patologia , Lipocalina-2/imunologia , Macrófagos/patologia , Camundongos , Camundongos Knockout , Pneumonia Bacteriana/genética , Pneumonia Bacteriana/patologia , Mucosa Respiratória/patologiaRESUMO
BACKGROUND: Both the human immunodeficiency virus (HIV) and hepatitis C virus (HCV), either alone or as coinfections, persist in their hosts by destroying and/or escaping immune defenses, with high morbidity as consequence. In some cases, however, a balance between infection and immunity is reached, leading to prolonged asymptomatic periods. We report a case of such an indolent co-infection, which could be explained by the development of a peculiar subset of Natural Killer (NK) cells. RESULTS: Persistently high peripheral levels of CD56+ NK cells were observed in a peculiar hemophiliac HIV/HCV co-infected patient with low CD4 counts, almost undetectable HIV viral load and no opportunistic infections. Thorough analysis of NK-subsets allowed to identify a marked increase in the CD56bright/dim cell ratio and low numbers of CD16+/CD56- cells. These cells have high levels of natural cytotoxicity receptors but low NCR2 and CD69, and lack both CD57 and CD25 expression. The degranulation potential of NK-cells which correlates with target cytolysis was atypically mainly performed by CD56bright NK-cells, whereas no production of interferon γ (IFN-γ) was observed following NK activation by K562 cells. CONCLUSIONS: These data suggest that the expansion and lytic capacity of the CD56bright NK subset may be involved in the protection of this « rare ¼ HIV/HCV co-infected hemophiliac A patient from opportunistic infections and virus-related cancers despite very low CD4+ cell counts.
Assuntos
Linfócitos T CD4-Positivos/imunologia , Antígeno CD56/análise , Infecções por HIV/complicações , Hemofilia A/complicações , Hepatite C/complicações , Células Matadoras Naturais/imunologia , Adulto , Contagem de Linfócito CD4 , Degranulação Celular , Infecções por HIV/imunologia , Hemofilia A/imunologia , Hepatite C/imunologia , Humanos , Células Matadoras Naturais/química , Masculino , Carga ViralRESUMO
A distinct pathologic entity characterized by expression of the anaplastic lymphoma kinase (ALK) protein (hence described as ALK lymphoma) has emerged within the heterogeneous group of CD30 anaplastic large-cell lymphomas. Central nervous system (CNS) involvement is extremely rare in anaplastic large-cell lymphoma. In children, only isolated cases have been reported, mainly as secondary CNS involvement. We report on a 13-year-old boy presenting with headaches and diplopia. Cerebrospinal fluid was infiltrated with atypical large granular lymphocytes. Magnetic resonance imaging of the brain revealed leptomeningeal enhancement. A frontal lobe biopsy showed a pleomorphic neoplasm diffusely infiltrating the meninges composed of large cells with bizarre nuclei similar to those evidenced in cerebrospinal fluid. Immunohistochemical stains showed diffuse strong positivity for CD8, CD30, anaplastic lymphoma kinase protein: p80 and negative monocyte-macrophage and B cell markers. TCR gamma was clonally rearranged. This finding was confirmed by reverse transcription-polymerase chain reaction analysis of the NPM/ALK fusion protein. Epstein-Barr virus was not detected. No evidence of extra-CNS disease was found by imaging study, cytologic examination, or molecular studies. The patient underwent complete remission with polychemotherapy followed by a CNS irradiation. At +10 months from onset, he suffered a full relapse. After a short-term remission with vinblastine, he underwent nonmyeloablative allogeneic bone marrow transplantation, but unfortunately died from multiple organ failure. This case is the first reported occurrence of a primary meningeal ALK lymphoma in a child.
Assuntos
Linfoma Anaplásico de Células Grandes/patologia , Neoplasias Meníngeas/patologia , Proteínas Tirosina Quinases/metabolismo , Adolescente , Quinase do Linfoma Anaplásico , DNA de Neoplasias/análise , Evolução Fatal , Rearranjo Gênico , Genes Codificadores da Cadeia gama de Receptores de Linfócitos T/genética , Humanos , Imunofenotipagem , Linfoma Anaplásico de Células Grandes/complicações , Linfoma Anaplásico de Células Grandes/tratamento farmacológico , Linfoma Anaplásico de Células Grandes/metabolismo , Masculino , Neoplasias Meníngeas/tratamento farmacológico , Neoplasias Meníngeas/metabolismo , Insuficiência de Múltiplos Órgãos , Proteínas Tirosina Quinases/líquido cefalorraquidiano , Proteínas Tirosina Quinases/genética , Receptores Proteína Tirosina QuinasesRESUMO
Multimerin 1 is a massive, soluble, disulfide-linked homopolymeric protein that is expressed in megakaryocytes, platelets and endothelial cells. Normally, multimerin 1 undergoes efficient sorting to secretion granules, and it is not detectable in plasma. Recently, multimerin 1 was designated as a member of the EMILIN protein family, a group of structurally similar, disulfide-linked multimeric proteins. Multimerin 1 has the structural features of an adhesive protein and it supports the adhesion of many different cell types in vitro, including activated platelets, neutrophils, and endothelial cells. Multimerin 1 also has the ability to self associate and form large, branching matrix fibers. In platelet alpha-granules, multimerin 1 functions as the binding protein for coagulation factor V, a key regulator of coagulation. This review summarizes the current knowledge on multimerin 1 including its orthologous genes, restricted pattern of expression, structure, biosynthesis and functions.
Assuntos
Proteínas Sanguíneas/fisiologia , Animais , Plaquetas/fisiologia , Proteínas Sanguíneas/química , Proteínas Sanguíneas/genética , Adesão Celular/fisiologia , Grânulos Citoplasmáticos/fisiologia , Células Endoteliais/fisiologia , Proteínas da Matriz Extracelular/fisiologia , Fator V/metabolismo , Humanos , Megacariócitos/fisiologia , Ativação Plaquetária , Agregação Plaquetária , Ligação Proteica , Transporte ProteicoRESUMO
Lipocalin-2 is a constituent of the neutrophil secondary granules and is expressed de novo by macrophages and epithelium in response to inflammation. Lipocalin-2 acts in a bacteriostatic fashion by binding iron-loaded siderophores required for bacterial growth. Mycobacterium tuberculosis (M.tb) produces siderophores that can be bound by lipocalin-2. The impact of lipocalin-2 in the innate immune response toward extracellular bacteria has been established whereas the effect on intracellular bacteria, such as M.tb, is less well-described. Here we show that lipocalin-2 surprisingly confers a growth advantage on M.tb in the early stages of infection (3 weeks post-challenge). Using mixed bone marrow chimeras, we demonstrate that lipocalin-2 derived from granulocytes, but not from epithelia and macrophages, leads to increased susceptibility to M.tb infection. In contrast, lipocalin-2 is not observed to promote mycobacterial growth at later stages of M.tb infection. We demonstrate co-localization of granulocytes and mycobacteria within the nascent granulomas at week 3 post-challenge, but not in the consolidated granulomas at week 5. We hypothesize that neutrophil-derived lipocalin-2 acts to supply a source of iron to M.tb in infected macrophages within the immature granuloma, thereby facilitating mycobacterial growth.
Assuntos
Granulócitos/imunologia , Granuloma/imunologia , Imunidade Inata , Lipocalina-2/imunologia , Macrófagos/imunologia , Mycobacterium tuberculosis/imunologia , Tuberculose/imunologia , Animais , Granulócitos/patologia , Granuloma/genética , Granuloma/microbiologia , Granuloma/patologia , Lipocalina-2/genética , Macrófagos/microbiologia , Macrófagos/patologia , Camundongos , Camundongos Knockout , Tuberculose/genética , Tuberculose/patologiaRESUMO
mRNA translation is mainly regulated at the level of initiation, a process that involves the synergistic action of the 5' cap structure and the 3' poly(A) tail at the ends of eukaryotic mRNA. The eukaryote initiation factor 4G(eIF4G) is a pivotal scaffold protein that forms a critical link between mRNA cap structure, poly(A) tail, and the small ribosomal subunit. There are two functional homologs of eIF4G in mammals, the original eIF4G, renamed eIF4GI, and eIF4GII that functionally complements eIF4GI. To date, biochemical and functional analysis have not identified differential activities for eIF4GI and eIF4GII. In this report, we demonstrate that eIF4GII, but not eIF4GI, is selectively recruited to capped mRNA at the onset of cell differentiation. This recruitment is coincident with a strong and long-lasting phosphorylation of eIF4E and the release of 4E-BP1, a suppressor of eIF4E function, from the cap structure, without a concomitant change in 4E-BP1's phosphorylation. Our data further indicate that cytokines such as thrombopoietin can differentially regulate eIF4GI/II activities. These results provide the first evidence that eIF4GI/II does fulfill selective roles in mammalian cells.
Assuntos
Diferenciação Celular/fisiologia , Fator de Iniciação 4E em Eucariotos/metabolismo , Fator de Iniciação 4F em Eucariotos/metabolismo , Humanos , Megacariócitos/metabolismo , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Fosforilação , Trombopoetina/metabolismoRESUMO
AIM: To estimate the risk of venous thrombosis associated with pancreatic adenocarcinoma and its consequences on treatment and survival. PATIENTS AND METHODS: We retrospectively analyzed a cohort of 90 patients (49 males, 41 females - median age: 67 years [range: 37-94]). Pancreatic adenocarcinoma was histologically proved in 72 patients (81%) and was metastatic in 49 patients (54.4%). A venous thrombosis was observed in 24 patients (26.7%). A pulmonary embolism occurred in 4 patients with 2 deaths. The risk of venous thrombosis was significantly reduced by the use of anti-thrombotic prophylaxis (HR: 0.03 [95CI: 0.003-0.27]) and increased among patients with a biological inflammatory syndrome (HR: 9.0 [95CI: 2.30-34.4]) and metastatic disease (HR: 4.4 [95CI: 1.1-17.9]). Overall survival was not different between patients with (6.6 months) or without (6.1 months) venous thrombosis. CONCLUSION: The risk of venous thrombosis is important and may delay the treatment in patients with advanced pancreatic carcinoma. Some patients with high risk of venous thrombosis may benefit from a prophylactic anticoagulant treatment.
Assuntos
Adenocarcinoma/complicações , Neoplasias Pancreáticas/complicações , Trombose Venosa/etiologia , Adenocarcinoma/secundário , Adulto , Idoso , Idoso de 80 Anos ou mais , Anticoagulantes/uso terapêutico , Cateteres de Demora , Causas de Morte , Estudos de Coortes , Feminino , Fibrinolíticos/uso terapêutico , Heparina de Baixo Peso Molecular/uso terapêutico , Humanos , Inflamação , Masculino , Pessoa de Meia-Idade , Embolia Pulmonar/etiologia , Estudos Retrospectivos , Fatores de Risco , Taxa de Sobrevida , Trombose Venosa/prevenção & controleRESUMO
Jumonji Domain-Containing Protein 3 (JMJD3)/lysine demethylase 6B (KDM6B) is an epigenetic modulator that removes repressive histone marks on genes. Expression of KDM6B mRNA is elevated in leukocytes from patients with ANCA-associated vasculitis (AAV) and has been suggested to be the reason for higher proteinase 3 (PR3) mRNA expression in these cells due to derepression of PRTN3 gene transcription. MicroRNA-941 (miR-941) has been shown to target KDM6B mRNA and inhibit JMJD3 production. We therefore investigated whether polymorphonuclear granulocytes (PMNs) from patients suffering from granulomatosis with polyangiitis (GPA) have lower expression of miR-941 than healthy control donors as a biological cause for higher JMJD3 levels. We found no significant difference in the degree of maturation of PMNs from GPA patients (n = 8) and healthy controls (n = 11) as determined from cell surface expression of the neutrophil maturation marker CD16 and gene expression profile of FCGR3B. The expression of PRTN3 and KDM6B mRNAs and miR-941 was not significantly different in GPA patients and healthy controls. Transfection of pre-miR-941 into the neutrophil promyelocyte cell line PLB-985 cells did not result in reduction of the KDM6B mRNA level as shown previously in a hepatocellular carcinoma cell line. The amount of PR3 in PMNs from GPA patients and healthy controls was comparable. In conclusion, we found that PRTN3 mRNA, KDM6B mRNA, and miR-941 expression levels in PMNs do not differ between GPA patients and healthy controls, and that miR-941 does not uniformly regulate KDM6B mRNA levels by inducing degradation of the transcript. Thus, decreased miR-941 expression in PMNs cannot be part of the pathogenesis of GPA.
Assuntos
Granulomatose com Poliangiite/patologia , MicroRNAs/metabolismo , Neutrófilos/metabolismo , Adulto , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Feminino , Proteínas Ligadas por GPI/genética , Proteínas Ligadas por GPI/metabolismo , Granulomatose com Poliangiite/genética , Granulomatose com Poliangiite/metabolismo , Humanos , Histona Desmetilases com o Domínio Jumonji/antagonistas & inibidores , Histona Desmetilases com o Domínio Jumonji/genética , Histona Desmetilases com o Domínio Jumonji/metabolismo , Masculino , Pessoa de Meia-Idade , Mieloblastina/genética , Mieloblastina/metabolismo , Análise de Componente Principal , RNA Mensageiro/metabolismo , Receptores de IgG/genética , Receptores de IgG/metabolismo , Transcriptoma , Adulto JovemRESUMO
Aspergillus fumigatus is an opportunistic fungal pathogen that causes severe invasive infections in immunocompromised patients. Innate immunity plays a major role in protection against A. fumigatus. The ficolins are a family of soluble pattern recognition receptors that are capable of activating the lectin pathway of complement. Previous in vitro studies reported that ficolins bind to A. fumigatus, but their part in host defense against fungal infections in vivo is unknown. In this study, we used ficolin-deficient mice to investigate the role of ficolins during lung infection with A. fumigatus. Ficolin knockout mice showed significantly higher fungal loads in the lungs 24 h postinfection compared to wild-type mice. The delayed clearance of A. fumigatus in ficolin knockout mice could not be attributed to a compromised recruitment of inflammatory cells. However, it was revealed that ficolin knockout mice exhibited a decreased production of proinflammatory cytokines in the lungs compared to wild-type mice following A. fumigatus infection. The impaired clearance and cytokine production in ficolin knockout mice was independent of complement, as shown by equivalent levels of A. fumigatus-mediated complement activation in ficolin knockout mice and wild-type mice. In conclusion, this study demonstrates that ficolins are important in initial innate host defense against A. fumigatus infections in vivo.
Assuntos
Aspergilose/imunologia , Aspergillus fumigatus/imunologia , Lectina de Ligação a Manose da Via do Complemento , Imunomodulação , Inflamação/imunologia , Lectinas/metabolismo , Receptores de Reconhecimento de Padrão/metabolismo , Animais , Células Cultivadas , Citocinas/metabolismo , Feminino , Imunidade Inata , Lectinas/genética , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Receptores de Reconhecimento de Padrão/imunologia , FicolinasRESUMO
Factor V is an essential coagulation cofactor that circulates in plasma and platelet alpha-granules where it is stored complexed to multimerin I (MMRN1). To gain insights into the origin and processing of human platelet factor V, and factor V-MMRN I complexes, we studied factorV in cultured megakaryocytes. Factor V mRNA was detected in all megakaryocyte cultures. However, like albumin, IgG and fibrinogen, factorV protein was detectable only in megakaryocytes cultured with exogenous protein. The amount of factor V associated with megakaryocytes was influenced by the exogenous factorV concentration. Similar to platelet factor V, megakaryocyte factor V was proteolyzed and complexed with megakaryocyte-synthesized MMRN1. With secretagogues, megakaryocytes released factor V, IgG, fibrinogen and MMRN1. Immunofluorescent and electron microscopy confirmed factorV uptake by endocytosis and its trafficking to megakaryocyte alpha-granules. These data provide direct evidence that human megakaryocytes process plasma-derived factor V into alpha-granules and generate factorV-MMRN I complexes from endogenously and exogenously synthesized proteins.
Assuntos
Endocitose , Fator V/metabolismo , Megacariócitos/metabolismo , RNA Mensageiro/metabolismo , Plaquetas/metabolismo , Proteínas Sanguíneas/metabolismo , Células da Medula Óssea/metabolismo , Células Cultivadas , Grânulos Citoplasmáticos/metabolismo , Fator V/genética , Fibrinogênio/metabolismo , Humanos , Imunoglobulina G/metabolismo , Plasma/metabolismo , Glicoproteína IIb da Membrana de Plaquetas/análise , Fatores de TempoRESUMO
Multimerin 1 (MMRN1) is a large, soluble, polymeric, factor V binding protein and member of the EMILIN protein family. In vivo, MMRN1 is found in platelets, megakaryocytes, endothelium and extracellular matrix fibers, but not in plasma. To address the mechanism of MMRN1 binding to activated platelets and endothelial cells, we investigated the identity of the major MMRN1 receptors on these cells using wild-type and RGE-forms of recombinant MMRN1. Ligand capture, cell adhesion, ELISA and flow cytometry analyses of platelet-MMRN1 binding, indicated that MMRN1 binds to integrins alphaIIbbeta3 and alphavbeta3. Endothelial cell binding to MMRN1 was predominantly mediated by alphavbeta3 and did not require the MMRN1 RGD site or cellular activation. Like many other alphavbeta3 ligands, MMRN1 had the ability to support adhesion of additional cell types, including stimulated neutrophils. Expression studies, using a cell line capable of endothelial-like MMRN1 processing, indicated that MMRN1 adhesion to cellular receptors enhanced its extracellular matrix fiber assembly. These studies implicate integrin-mediated binding in MMRN1 attachment to cells and indicate that MMRN1 is a ligand for alphaIIbbeta3 and alphavbeta3.
Assuntos
Plaquetas/metabolismo , Proteínas Sanguíneas/metabolismo , Integrina alfaVbeta3/metabolismo , Complexo Glicoproteico GPIIb-IIIa de Plaquetas/metabolismo , Linhagem Celular , Células Endoteliais/metabolismo , Células Endoteliais/ultraestrutura , Matriz Extracelular/metabolismo , Matriz Extracelular/ultraestrutura , Humanos , Técnicas In Vitro , Rim/citologia , Ligantes , Megacariócitos/metabolismo , Microscopia ImunoeletrônicaRESUMO
Antibodies directed against the glycoprotein (GP) Ib have been identified as the potential cause of various platelet disorders: Immune thrombocytopenic purpura (ITP) may be caused by such autoantibodies; Anti-thrombotic drugs targeting GPIb also induce thrombocytopenia. In order to elucidate the potential mechanism(s) of the anti-GPIb effects, we have examined by electron microscopy (EM) the effect of several antibodies directed against GPIb and GPIIb-IIIa on human culture megakaryocytes (MK). Virtually all antibodies to GPIb enhanced the interaction of newly formed platelets with MK when compared to other antibodies. These effects were retrieved when antibodies were tested on platelets. We conclude that antibodies to GPIb can potentially inhibit platelet release by MK, and can also induce homotypic platelet adhesion. These results may have implications in the pathophysiology of thrombocytopenia and platelet recovery in ITP, and shed light on the pathological effect of anti-GPIb antibodies used as antithrombotic drugs.
Assuntos
Anticorpos/farmacologia , Plaquetas/imunologia , Plaquetas/patologia , Megacariócitos/imunologia , Megacariócitos/patologia , Complexo Glicoproteico GPIb-IX de Plaquetas/imunologia , Anticorpos Monoclonais/farmacologia , Autoanticorpos/sangue , Cálcio/farmacologia , Adesão Celular , Células Cultivadas , Fibrinolíticos/farmacologia , Humanos , Concentração de Íons de Hidrogênio , Técnicas In Vitro , Integrina beta3/imunologia , Microscopia Eletrônica , Agregação Plaquetária/efeitos dos fármacos , Agregação Plaquetária/imunologia , Glicoproteína IIb da Membrana de Plaquetas/imunologia , Púrpura Trombocitopênica Idiopática/sangue , Púrpura Trombocitopênica Idiopática/imunologia , Receptores Fc/metabolismoRESUMO
alpha-Granule protein storage is important for producing platelets with normal haemostatic function. The low to undetectable levels of several megakaryocyte-synthesized alpha-granule proteins in normal plasma suggest megakaryocytes are important to sequester these proteins in vivo. alpha-Granule protein storage in vitro has been studied using other cell types, with differences observed in how some proteins are processed compared to platelets. Human megakaryocytes, cultured from cord blood CD34(+) cells and grown in serum-free media containing thrombopoietin, were investigated to determine if they could be used as a model for studying normal alpha-granule protein processing and storage. ELISA indicated that cultured megakaryocytes contained the alpha-granule proteins multimerin, von Willebrand factor, thrombospondin-1, beta-thromboglobulin and platelet factor 4, but no detectable fibrinogen and factor V. A significant proportion of the alpha-granule protein in megakaryocyte cultures was contained within the cells (averages: 41-71 %), consistent with storage. Detailed analyses of multimerin and von Willebrand factor confirmed that alpha-granule proteins were processed to mature forms and were predominantly located in the alpha-granules of cultured megakaryocytes.Thrombopoietin-stimulated cultured megakaryocytes provide a useful model for studying alpha-granule protein processing and storage.
Assuntos
Grânulos Citoplasmáticos/química , Megacariócitos/química , Proteínas/metabolismo , Proteínas Sanguíneas/análise , Proteínas Sanguíneas/metabolismo , Células Cultivadas , Humanos , Megacariócitos/citologia , Megacariócitos/ultraestrutura , Fator Plaquetário 4/análise , Fator Plaquetário 4/metabolismo , Proteínas/análise , Trombopoetina/farmacologia , Trombospondina 1/análise , Trombospondina 1/metabolismo , beta-Tromboglobulina/análise , beta-Tromboglobulina/metabolismo , Fator de von Willebrand/análise , Fator de von Willebrand/metabolismoRESUMO
Paris-Trousseau syndrome (PTS) is an inherited disorder characterized by mild hemorragic tendency associated with 11q chromosome deletion. Here we report ten new patients (5 boys, 5 girls) with complete clinical history, biological data, ultra-structural and molecular investigations. Thrombocytopenia is chronic in all the patients except two boys in whom it disappeared during the two first years of life. On Romanovsky stained peripheral blood smears, abnormal platelets with giant granules were detected in all the children and confirmed by electron microscopy (EM). On bone marrow smears, dysmegakaryopoiesis with many micromegakaryocytes was constantly observed. Abnormal alpha-granules were virtually absent from bone marrow and cultured megakaryocytes, while EM detected numerous images of granule fusion within blood platelets. Molecular analyses evidenced that the fli-1 gene is deleted in all the patients except one confirming the crucial role of the transcription factor FLI-1 in megakaryopoiesis. In summary, this study documents ten new cases of PTS with characteristic alpha-granule abnormalities, and shows the putative pathogenic role of fli-1 gene in the pathophysiology of this syndrome.
Assuntos
Transtornos Plaquetários/patologia , Proteínas Proto-Oncogênicas , Trombocitopenia/patologia , Transtornos Plaquetários/etiologia , Transtornos Plaquetários/genética , Plaquetas/patologia , Plaquetas/ultraestrutura , Pré-Escolar , Grânulos Citoplasmáticos/patologia , Proteínas de Ligação a DNA/genética , Saúde da Família , Feminino , Deleção de Genes , Humanos , Lactente , Masculino , Microscopia Eletrônica , Proteína Proto-Oncogênica c-fli-1 , Síndrome , Trombocitopenia/etiologia , Trombocitopenia/genética , Trombopoese/genética , Transativadores/genéticaRESUMO
The study presented here, performed on the bone marrow from patients with idiopathic myelofibrosis (MF) and on a murine model of MF, demonstrates a pathological interaction between PMN leukocytes and megakaryocyte (Mk), correlated with MF development. The data obtained revealed abnormal subcellular P-selectin distribution, which appeared to correlate with excessive and pathological emperipolesis of PMN leukocytes within Mk, leading to the destruction of Mk storage organelles and leakage of alpha-granular contents into the bone marrow microenvironment. The prominent role of growth factors, PDGF and TGFbeta, stored in the Mk alpha-granular compartment in the generation of MF has been previously largely documented. Both growth factors are essential for the Mk-dependent fibroblast proliferation. The destructive mutual cellular interaction of Mk and PMN leading to the pathological release of PDGF and TGFbeta within the bone marrow microenvironment may participate, through fibroblast activation, to the generation of MF. Therefore, this study provides insight into the possible pathophysiological mechanisms for the genesis of MF.
Assuntos
Comunicação Celular , Megacariócitos/fisiologia , Neutrófilos/fisiologia , Mielofibrose Primária/etiologia , Animais , Medula Óssea/ultraestrutura , Divisão Celular , Modelos Animais de Doenças , Humanos , Megacariócitos/ultraestrutura , Camundongos , Microscopia Eletrônica , Selectina-P/análise , Mielofibrose Primária/patologia , Trombopoetina/genéticaRESUMO
NGAL/lipocalin-2 is a siderophore-binding protein that is highly expressed in several cancers. It is suggested to confer a proliferative advantage to cancer cells. Its expression has been correlated with aggressiveness of breast cancer as determined both in patients and in mouse breast cancer models. This was recently confirmed in two mouse models of spontaneous breast cancer in wild-type and lipocalin-2-deficient mice. We used a similar strategy using a different mouse strain. Lipocalin-2-deficient mice and mouse mammary tumor virus-polyoma middle T antigen (MMTV-PyMT) mice were crossed into the same FVB/N background. All mice developed tumors by week 8. The mice were sacrificed on week 13 and tissue was processed for biochemical and histological analysis. The total tumor volume and number of metastases were quantitated in 26 lipocalin-2-deficient mice and 34 wild-type controls. Lipocalin-2 expression in tumors of MMTV-PyMT-positive and wild-type mice was assessed by quantitative real-time PCR and by immunohistochemistry. The expression of the lipocalin-2 receptors 24p3R and megalin and of Mmp-9, transferrin receptor, and Bdh2 (a producer of a mammalian siderophore) were quantitated by real-time PCR. No significant difference was observed between wild-type and lipocalin-2-deficient mice. Lipocalin-2 was highly expressed in tumors from wild-type mice, but the expression did not correlate with tumor size. No effect of lipocalin-2 was observed with respect to time to tumor appearance, total tumor volume, or to the number of metastases. Histology and gelatinolytic activity of the mammary tumors did not differ between wild-type and lipocalin-2-deficient mice. We conclude that NGAL/lipocalin-2 does not invariably affect the aggressiveness of breast cancers as assessed in mouse models, thus questioning the role of lipocalin-2 in cancer development.
Assuntos
Proteínas de Fase Aguda/metabolismo , Lipocalinas/metabolismo , Proteínas Oncogênicas/metabolismo , Animais , Antígenos Transformantes de Poliomavirus/metabolismo , Linhagem Celular Tumoral , Modelos Animais de Doenças , Feminino , Regulação Neoplásica da Expressão Gênica , Granulócitos/citologia , Humanos , Imuno-Histoquímica/métodos , Lipocalina-2 , Proteína-2 Relacionada a Receptor de Lipoproteína de Baixa Densidade/biossíntese , Masculino , Metaloproteinase 9 da Matriz/biossíntese , Camundongos , Camundongos Knockout , Receptores de Superfície Celular/biossíntese , Receptores da Transferrina/biossínteseRESUMO
OLFM4 was identified initially as a gene highly induced in myeloid stem cells by G-CSF treatment. A bioinformatics method using a global meta-analysis of microarray data predicted that OLFM4 would be associated with specific granules in human neutrophils. Subcellular fractionation of peripheral blood neutrophils demonstrated complete colocalization of OLFM4 with the specific granule protein NGAL, and stimulation of neutrophils with PMA resulted in corelease of NGAL and OLFM4, proving that OLFM4 is a genuine constituent of neutrophil-specific granules. In accordance with this, OLFM4 mRNA peaked at the MY/MM stage of maturation. OLFM4 was, however, present in only 20-25% of peripheral blood neutrophils, as determined by immunocytochemistry and flow cytometry, whereas mRNA for OLFM4 was present in all MY/MM, indicating post-transcriptional regulation as a basis for the heterogeneous expression of OLFM4 protein.
Assuntos
Fator Estimulador de Colônias de Granulócitos/metabolismo , Neutrófilos/classificação , Neutrófilos/metabolismo , Células da Medula Óssea/efeitos dos fármacos , Células da Medula Óssea/metabolismo , Diferenciação Celular/genética , Fator Estimulador de Colônias de Granulócitos/genética , Fator Estimulador de Colônias de Granulócitos/farmacologia , Humanos , Células Mieloides/efeitos dos fármacos , Células Mieloides/metabolismo , Neutrófilos/efeitos dos fármacos , Transporte Proteico/fisiologia , RNA Mensageiro/metabolismoAssuntos
Bioensaio/métodos , Diferenciação Celular/fisiologia , Membrana Celular/metabolismo , Citoplasma/metabolismo , Grânulos Citoplasmáticos/metabolismo , Megacariócitos/metabolismo , Fosfatase Alcalina , Animais , Membrana Celular/ultraestrutura , Imunofluorescência/métodos , Humanos , Imuno-Histoquímica/métodos , Megacariócitos/citologia , Megacariócitos/ultraestrutura , Microscopia Imunoeletrônica/métodosRESUMO
INTRODUCTION: Non-melanoma skin cancer (NMSC) increases the rate of morbidity and mortality in kidney transplant patients. Studies have shown that kidney transplanted patients have at least a 3-4-fold increased risk of cancers. Organ-transplanted (OT) patients therefore constitute a known and growing risk population. Careful information of the patient and prophylactic measures are thus strongly indicated. MATERIAL AND METHODS: A questionnaire was sent to 110 kidney-transplanted patients in Region Sjaelland, Denmark. Patients were identified through Nephrology Departments. A total of 75 patients responded. The object of the questionnaire was to describe the level of information among the patients and the scope and frequency of any skin examination they underwent following transplantation. RESULTS: Responders did not differ from non-responders regarding gender and age. Among the responders, 22 (29%) had received oral information prior to transplantation and 38 (51%) after transplantation. A total of nine (12%) patients had received written information prior to transplantation and 18 (24%) after. In all, 39 (53%) were well-informed on their increased risk of NMSC. Only four patients (5%) had their skin and lymph nodes examined at follow-up visits by the physician responsible for the proper functioning of the transplant. CONCLUSION: This study shows that kidney transplanted patients do not receive adequate information about increased risk of skin cancer and the necessity of photoprotection. Furthermore, the rate of examination by a dermatologist is very low. Both parameters could be improved by a structured plan for patient information and follow-up visits.
Assuntos
Transplante de Rim/efeitos adversos , Neoplasias Cutâneas/etiologia , Adulto , Feminino , Seguimentos , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Hospedeiro Imunocomprometido , Transplante de Rim/imunologia , Linfonodos/patologia , Masculino , Pessoa de Meia-Idade , Educação de Pacientes como Assunto , Fatores de Risco , Pele/patologia , Neoplasias Cutâneas/imunologia , Neoplasias Cutâneas/prevenção & controle , Inquéritos e Questionários , Raios Ultravioleta/efeitos adversosRESUMO
Platelets are released by megakaryocytes (MKs) via cytoplasmic extensions called proplatelets, which require profound changes in the microtubule and actin organization. Here, we provide evidence that the Rho/ROCK pathway, a well-known regulator of actin cytoskeleton, acts as a negative regulator of proplatelet formation (PPF). Rho is expressed at a high level during the entire MK differentiation including human CD34(+) cells. Thrombopoietin stimulates its activity but at a higher extent in immature than in mature MKs. Overexpression of a dominant-negative or a spontaneously active RhoA leads to an increase or a decrease in PPF indicating that Rho activation inhibits PPF. This inhibitory effect is mediated through the main Rho effector, Rho kinase (ROCK), the inhibition of which also increases PPF. Furthermore, inhibition of Rho or ROCK in MKs leads to a decrease in myosin light chain 2 (MLC2) phosphorylation, which is required for myosin contractility. Interestingly, inhibition of the MLC kinase also decreases MLC2 phosphorylation while increasing PPF. Taken together, our results suggest that MLC2 phosphorylation is regulated by both ROCK and MLC kinase and plays an important role in platelet biogenesis by controlling PPF and fragmentation.